Lada Ryan 4

4 · James Hardie Industries plc · Filed Jun 17, 2026

AI-generated summary of this filing

Updated Jun 17, 2026

James Hardie (JHX) CFO Lada Ryan Exercises Options, Receives Awards

What Happened

Lada Ryan, Chief Financial Officer of James Hardie Industries plc (JHX), exercised 7,700 stock options on 2026-06-16. The exercise is reported as 7,700 shares at $24.45 per share (total value $188,265).
To cover the exercise price and tax withholding, the issuer withheld/surrendered 7,495 shares on 2026-06-16 valued at $25.48 per share (total ~$190,973). Net shares retained from the exercise were approximately 205 shares.
On 2026-06-15 Ryan was also granted awards: 11,422 restricted stock units (RSUs) and 14,232 non-qualified option units (derivative grant) (both $0 reported as grant price).

Key Details

Transaction dates and prices:
- 2026-06-15: Grants — 11,422 RSUs (F1) and 14,232 option/derivative awards (F2/F4) at $0.00 (award).
- 2026-06-16: Option exercise — 7,700 shares @ $24.45 (acquired; $188,265).
- 2026-06-16: Shares withheld to satisfy exercise price/taxes — 7,495 shares @ $25.48 (disposed; ~$190,973) (F3).
Shares owned after transaction: Not disclosed in the provided Form 4 details.
Notable footnotes:
- F1: RSUs vest in three equal annual installments beginning on the first anniversary of the grant, subject to continued service.
- F2: Annual long‑term incentive grant (more detail to appear in the 2026 proxy statement).
- F3: Shares were withheld by the issuer to satisfy exercise price and tax obligations (typical cashless/withholding procedure).
- F4: Non‑qualified stock options vest in three equal annual installments starting on the first anniversary.
Filing timeliness: Form 4 filed 2026-06-17 covering transactions on 2026-06-15 and 06-16; this filing date is within the usual two-business-day reporting window.

Context

This was an option exercise with most of the resulting shares withheld to cover the exercise and tax obligations — a common cashless exercise procedure, not an open-market sale. The key actionable items for investors are the new RSU and option grants (long-term compensation) and that the exercise did not result in a large market sale.
Awards (RSUs and options) vest over multiple years (three equal annual installments), so these are compensation/retention actions rather than immediate purchases or indications of a large insider sale.

Form 4

Period: 2026-06-15

CFO

Transactions

Award
Ordinary shares
[F1][F2]
2026-06-15+11,422→ 69,809 total
Exercise/Conversion
Ordinary shares
2026-06-16$24.45/sh+7,700$188,265→ 77,509 total
Tax Payment
Ordinary shares
[F3]
2026-06-16$25.48/sh−7,495$190,973→ 70,014 total
Award
Employee Stock Option (Right to Buy)
[F4]
2026-06-15+14,232→ 14,232 total
Exercise: $25.17Exp: 2036-06-15→ Ordinary shares (14,232 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2026-06-16$24.45/sh−7,700$188,265→ 0 total
Exercise: $24.45From: 2025-07-11Exp: 2026-07-11→ Ordinary shares (7,700 underlying)

Footnotes (4)

[F1]Consists of restricted stock units (RSU). RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to continued service through the applicable vesting date.
[F2]Annual grant made pursuant to the issuer's fiscal year 2027 long-term incentive plan. Additional information will be included in the issuer's 2026 proxy statement.
[F3]Shares withheld by the Issuer to satisfy exercise price and tax obligations in connection with the exercise of employee stock options (right to buy) granted to the Reporting Person.
[F4]Non-qualified stock options vest in three equal annual installments beginning on the first anniversary of the grant date, subject to continued service through the applicable vesting date.

Signature

/s/ Aoife Rockett, as attorney-in-fact for Ryan Lada|2026-06-17

1 file